跳至主要内容
临床试验/NCT02209142
NCT02209142已完成不适用

Blood Biomarkers in Major Depression

Assistance Publique Hopitaux De Marseille2 个研究点 分布在 1 个国家目标入组 275 人开始时间: 2012年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
275
试验地点
2
主要终点
describe a transcriptional signature of the Major Depressive Episode.

研究概览

简要总结

Depression is a leading cause of disability worldwide, affecting nearly 16% of the general population. Its physiopathology remains unclear. Based on gene-environment studies and epigenetic studies, a main hypothesis proposed that the major depressive episode (MDE) results from the convergence of multiple factors including biological factors such as multi-genic vulnerability, hormonal and immunological variations as well as environmental factors. As a consequence, mRNA could define a biological signature of the MDE.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Major depressive disorder at inclusion according to the DSM IV at the time of the inclusion,
  • Having a score on the scale of depression of Hamilton ( HDRS-17) > 19 at the time of the inclusion,
  • Taken care by a grown-up psychiatric department, that the coverage(care) is realized in ambulatory or during a hospitalization

排除标准

  • Schizophrenia

结局指标

主要结局

describe a transcriptional signature of the Major Depressive Episode.

时间窗: 6 months

The major aim of our study is to compare the expression level of selected genes between patient suffering from major depression and control subjects and within patients across the MDE evolution. We plan to describe a transcriptional signature of the MDE.

次要结局

  • evaluate the role played by confounding factors as genetic polymorphisms,(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验